I understand the Chairman and CEO are travelling visiting the SE Asian sites.
It has been concerning at the 'glacial' pace of 'growing the business' as outlined in the reports, slide presentations etc over the last 2-3 years.
It is 18 months since they announced a relationship with Jointown Pharmaceutical in China to enter the Chinese market. What has happened? Zilch, Zero so it seems.
Delays, time lost has an opportunity cost to the business and shareholders. One wonders whether the current CEO is really up to the job.
We only have to look at the advance of Blackmores (and its share price) to see what is possible.
The full year (31 Dec 2017) results to be issued later in February, should likely be around same time as last year, about 20th?
I understand the Chairman and CEO are travelling visiting the SE...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add VLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.08 |
Change
0.020(0.97%) |
Mkt cap ! $131.4M | |||
| Open | High | Low | Value | Volume |
| $2.09 | $2.11 | $2.08 | $59.13K | 28.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 247 | $2.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.10 | 7231 | 2 |
View Market Depth
| Last trade - 15.14pm 22/11/2024 (20 minute delay) ? |
| VLS (ASX) Chart |
